Nelson Sun's most recent trade in Aardvark Therapeutics Inc. was a trade of 209,826 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics Inc. | Nelson Sun | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 209,826 | 209,826 | - | - | Stock Option (right to buy) | |
| Aardvark Therapeutics Inc. | Nelson Sun | Chief Financial Officer | 14 Feb 2025 | 59,332 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Aardvark Therapeutics Inc. | Nelson Sun | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2025 | 10,000 | 99,484 | - | 16 | 160,000 | Common Stock |
| Aardvark Therapeutics Inc. | Nelson Sun | Chief Financial Officer | 14 Feb 2025 | 7,001 | 89,484 | - | - | Common Stock |